--- title: "Ulcerative Colitis XmAb942-01 | Sutter Health" description: "A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis. XmAb942-01" url: "https://www.sutterhealth.org/research/clinical-trials/ulcerative-colitis-xmab942-01-2064309878" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Clinical trials](https://www.sutterhealth.org/research/clinical-trials) / 4. Ulcerative Colitis XmAb942-01 # Ulcerative Colitis XmAb942-01 **Status:** Open to Enrollment [Email us to enroll](https://www.sutterhealth.org/research/clinical-trials/ulcerative-colitis-xmab942-01-2064309878#enroll) #### Study details View study details on [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06619990). #### Locations - Palo Alto - Berkeley #### Clinical trial FAQs Information for patients and study volunteers, including [frequently asked questions](https://www.sutterhealth.org/research/faqs). A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis. XmAb942-01 ![Ryan A McConnell, M.D.](https://dyn.mktgcdn.com/p/LAIgIdYkiJk-DXnAW0o98yR3oSpGumxcc1pavHU7STQ/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100) Ryan A McConnell, M.D. Principal investigator [View profile](https://www.sutterhealth.org/research/investigators/ryan-a-mcconnell-md-1078064874) ## Sub-Investigators [Abhik Roy, M.D.](https://www.sutterhealth.org/research/investigators/abhik-roy-md-2064309876) , [Amy Yu, M.D.](https://www.sutterhealth.org/research/investigators/amy-yu-md-2064309832) ## Email us to enroll - [Email Palo Alto](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Ulcerative%20Colitis%20XmAb942-01%20in%20Palo%20Alto&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) - [Email Berkeley](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Ulcerative%20Colitis%20XmAb942-01%20in%20Berkeley&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) ## Related clinical trials [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) - Clinical trial ### [Inflammatory Bowel Disease QUOTIENT](https://www.sutterhealth.org/research/clinical-trials/quotient-1049141942) Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission **Status:** Open to Enrollment - Clinical trial ### [Inflammatory Bowel Disease BOOM-IBD2](https://www.sutterhealth.org/research/clinical-trials/inflammatory-bowel-disease-boom-ibd2-2007479061) BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of Inflammatory Bowel Disease (IBD). **Status:** Open to Enrollment - Clinical trial ### [Stress Urinary Incontinence PAS001 ProACT](https://www.sutterhealth.org/research/clinical-trials/stress-urinary-incontinence-pas001-proact-2080051902) Post Approval Study of the ProACT™ Adjustable Continence Therapy for Men **Status:** Open to Enrollment - Clinical trial ### [Chronic Nausea and Vomiting NAVIGATE](https://www.sutterhealth.org/research/clinical-trials/chronic-nausea-and-vomiting-navigate-2023207930) A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System **Status:** Open to Enrollment - Clinical trial ### [Gastroparesis EXPEDITE](https://www.sutterhealth.org/research/clinical-trials/gastroparesis-expedite-2007479109) Examination of Programming with the Enterra® Therapy System (EXPEDITE) in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation **Status:** Open to Enrollment [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/clinical-trials/ulcerative-colitis-xmab942-01-2064309878#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Clinical trials","item":"https://www.sutterhealth.org/research/clinical-trials"},{"@type":"ListItem","position":4,"name":"Ulcerative Colitis XmAb942-01"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/clinical-trials/ulcerative-colitis-xmab942-01-2064309878#medicalwebpage","name":"Ulcerative Colitis XmAb942-01","description":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis. XmAb942-01","url":"https://www.sutterhealth.org/research/clinical-trials/ulcerative-colitis-xmab942-01-2064309878","inLanguage":"en-US","dateModified":"2026-07-29","publisher":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/clinical-trials/ulcerative-colitis-xmab942-01-2064309878#medicaltrial"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/clinical-trials/ulcerative-colitis-xmab942-01-2064309878#breadcrumblist"},"mentions":[{"@type":"Person","name":"Ryan A McConnell, M.D.","url":"https://www.sutterhealth.org/research/investigators/ryan-a-mcconnell-md-1078064874","jobTitle":"Principal Investigator","affiliation":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"}}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalTrial","@id":"https://www.sutterhealth.org/research/clinical-trials/ulcerative-colitis-xmab942-01-2064309878#medicaltrial","name":"Ulcerative Colitis XmAb942-01","alternateName":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis. XmAb942-01","url":"https://www.sutterhealth.org/research/clinical-trials/ulcerative-colitis-xmab942-01-2064309878","description":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis. XmAb942-01","identifier":"NCT06619990","code":{"@type":"MedicalCode","codeValue":"NCT06619990","codingSystem":"ClinicalTrials.gov"},"sameAs":"https://clinicaltrials.gov/study/NCT06619990","status":"https://schema.org/Recruiting","healthCondition":[{"@type":"MedicalCondition","name":"Ulcerative Colitis"}],"studyLocation":[{"@type":"AdministrativeArea","name":"Palo Alto"},{"@type":"AdministrativeArea","name":"Berkeley"}]} ```